
The release of generic versions of brand name drugs for patients with multiple sclerosis had little overall effect on the price increase.

The release of generic versions of brand name drugs for patients with multiple sclerosis had little overall effect on the price increase.

Top news of the day from across the health care landscape.

During a health care conference on Thursday, Republican Federal Trade Commissioner Christine Wilson expressed support for allowing Medicare to negotiate drug prices.1

Teprotumumab-trbw is the first drug to be approved for the treatment of thyroid eye disease.

A case of the virus that reportedly originated in Wuhan City, China has been confirmed in Washington State.

Top news of the day from across the health care landscape.

Antiretroviral therapy may not be entirely effective in restoring the immune protection resulting from viral infections or childhood vaccines received prior to becoming HIV-positive.

The report projects changes in upcoming health care markets, including kidney care, digital health, drug cost transparency, the loneliness epidemic, and the self-care market.

According to a survey commissioned by the American Academy of Family Physicians, certain groups, including millennials and African Americans, are more susceptible to anti-vaccination rhetoric and beliefs, with 51% of Americans reporting they have not received a flu shot this season. In addition, nearly one-third of adults who completed the survey do not plan on getting a flu shot.

Since 2006, the CDC has tracked increases in cases and outbreaks about every 5 years.

Girish Dighe, PharmD, MS, explains the importance of change management within a closed-loop system.

The findings support the inclusion of these patient populations in ICI-based clinical trials and treatment.

Safety net providers, which historically work in underserved communities, have successfully petitioned state legislatures to take action on 340B 2-tier pricing.

Although there are many great benefits of mail-order pharmacy, there are times when it may not be the right choice.

Top news of the day from across the health care landscape.

Why is AR experiencing vision disturbances?

ADHD is correlated with lower health-related quality of life that starts in childhood and can persist into adulthood.

The Pharmacy HIT Collaborative released a revised draft version of pharmacy value sets, and is requesting comments from stakeholders.

Sensors that can be attached to insulin pens, smart auto-injectors for patients with MS, sensors for inhalers, smart pill bottles, and bioingestible sensors are some of the evolving technologies.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

In the third part of the series analyzing results from the Pharmacy Times Salary and Job Satisfaction Survey, we further explore pharmacists' satisfaction with their jobs and the factors that contribute to their overall happiness in a position.

Hospitalization offers unique opportunities to engage out-of-care individuals with the ultimate goal of improving their HIV outcomes and reducing health disparities.

Avapritinib was awarded FDA approval on Jan 9.

The ErbB inhibitors, gefitinib, erbstatin, and tryphostin AG825, inhibit a cell signaling process controlling the death-rate of neutrophils, immune cells, which cause damage to the lungs.

The app takes the authoritative, evidence-based 2015 World Health Organization pre-exposure prophylaxis guidelines and adapts for a mobile device.

Nexafed Decongestant Tablets are now available and in-stock from all wholesalers to relieve nasal and sinus congestion for patients.

The medication is newly indication for reducing the risk of major adverse cardiovascular events (MACE) including cardiovascular death, nonfatal heart attack, or nonfatal stroke in adults with type 2 diabetes and established cardiovascular disease (CVD).

What pharmacist created the famous soda, Coca-Cola, on May 8, 1886?

Counties in Medicaid expansion states saw an 11% lower rate of heroin deaths and a 10% lower rate of deaths involving synthetic opioids compared with counties in non-expansion states.